Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: iodine; iodine containing / vancomycin attending: chief complaint: left 4th toe infection major surgical or invasive procedure: : left superficial femoral artery to dorsalis pedis bypass graft with in-situ sphenous vein : left fourth toe debridement history of present illness: 48 y/o male well known to dr presents to clinic with 4th toe infection. patient has been having low grade fevers at home x 3 weeks. denies cp/sob/calf pain. past medical history: dm 1 htn pvd appy hernia repair social history: non contrib family history: diabetes physical exam: gen: nad pulm: cta b/l card: rrr, no murmurs , rubs or gallops abd: nt/nd le: right foot : s/p tma left foot: non palpable dp and pt 4tth toe with 1 cm ulceration + escar, dusky appearance, + serous drainage, + erythema pertinent results: 05:45am blood wbc-8.9 rbc-3.03* hgb-9.2* hct-25.9* mcv-85 mch-30.2 mchc-35.5* rdw-13.8 plt ct-250 05:40pm blood hct-27.5* 05:35am blood wbc-9.3 rbc-3.13* hgb-9.0* hct-26.6* mcv-85 mch-28.9 mchc-33.9 rdw-14.1 plt ct-232 05:43pm blood hct-25.7* 05:37am blood wbc-8.9 rbc-3.26* hgb-9.8*# hct-27.9* mcv-85 mch-30.0 mchc-35.1* rdw-13.8 plt ct-244 09:04pm blood hct-26.2* 10:57am blood hct-23.0* 07:02am blood wbc-10.4 rbc-2.66* hgb-7.8* hct-23.0* mcv-86 mch-29.5 mchc-34.1 rdw-13.7 plt ct-267 08:52pm blood wbc-11.1* rbc-3.36* hgb-10.3* hct-28.8* mcv-86 mch-30.6 mchc-35.8* rdw-13.4 plt ct-311 05:00am blood wbc-10.5 rbc-4.26* hgb-12.4* hct-36.5* mcv-86 mch-29.2 mchc-34.0 rdw-13.3 plt ct-379 03:52am blood wbc-8.7 rbc-3.75* hgb-11.0* hct-32.4* mcv-86 mch-29.4 mchc-34.1 rdw-13.4 plt ct-382 05:15am blood wbc-8.2 rbc-3.52* hgb-10.6* hct-31.1* mcv-88 mch-30.1 mchc-34.1 rdw-13.2 plt ct-333 05:45am blood wbc-9.3 rbc-3.66* hgb-11.0* hct-31.9* mcv-87 mch-30.0 mchc-34.4 rdw-12.9 plt ct-334 07:35am blood wbc-8.0 rbc-3.74* hgb-10.9* hct-31.9* mcv-85 mch-29.1 mchc-34.1 rdw-13.2 plt ct-327 06:40am blood wbc-9.5 rbc-3.55* hgb-10.7* hct-30.7* mcv-87 mch-30.1 mchc-34.8 rdw-13.3 plt ct-271 06:00am blood wbc-11.0 rbc-3.51* hgb-10.2* hct-30.7* mcv-87 mch-29.0 mchc-33.2 rdw-13.5 plt ct-253 07:05pm blood wbc-13.4*# rbc-3.65* hgb-11.2*# hct-31.3* mcv-86 mch-30.6 mchc-35.7* rdw-13.4 plt ct-276 05:45am blood plt ct-250 05:45am blood pt-12.9 inr(pt)-1.0 05:35am blood plt ct-232 05:37am blood plt ct-244 05:37am blood pt-13.1 ptt-30.0 inr(pt)-1.1 09:04pm blood ptt-29.3 07:02am blood plt ct-267 07:02am blood pt-13.1 ptt-29.6 inr(pt)-1.1 08:52pm blood plt ct-311 05:10am blood pt-12.9 ptt-56.3* inr(pt)-1.1 08:20pm blood ptt-61.1* 12:45pm blood ptt-53.5* 04:30am blood pt-12.7 ptt-45.8* inr(pt)-1.0 07:28pm blood ptt-49.4* 12:30pm blood pt-12.7 ptt-38.1* inr(pt)-1.0 05:00am blood plt ct-379 05:00am blood pt-12.7 ptt-42.2* inr(pt)-1.0 08:21pm blood ptt-42.6* 05:40am blood ptt-42.8* 09:20pm blood ptt-40.3* 01:59pm blood ptt-41.2* 03:52am blood plt ct-382 03:52am blood pt-16.0* ptt-33.7 inr(pt)-1.6 04:40pm blood ptt-36.1* 05:15am blood plt ct-333 05:15am blood pt-17.1* ptt-35.3* inr(pt)-1.8 09:25pm blood ptt-32.8 05:45am blood plt ct-334 05:45am blood pt-17.1* ptt-40.3* inr(pt)-1.8 07:35am blood plt ct-327 06:35am blood pt-16.8* ptt-35.8* inr(pt)-1.8 06:40am blood plt ct-271 06:40am blood pt-15.7* ptt-28.6 inr(pt)-1.6 06:00am blood plt ct-253 06:00am blood pt-15.1* ptt-33.9 inr(pt)-1.4 07:05pm blood plt ct-276 07:05pm blood pt-15.5* ptt-27.4 inr(pt)-1.5 05:45am blood glucose-97 urean-10 creat-0.9 na-138 k-3.8 cl-104 hco3-26 angap-12 05:35am blood glucose-163* urean-11 creat-1.0 na-136 k-3.7 cl-102 hco3-26 angap-12 05:37am blood glucose-186* urean-12 creat-0.9 na-136 k-4.2 cl-104 hco3-26 angap-10 04:57am blood glucose-204* urean-13 creat-1.0 na-137 k-4.8 hco3-24 08:52pm blood glucose-274* urean-12 creat-1.0 na-137 k-4.8 cl-108 hco3-23 angap-11 05:00am blood glucose-58* urean-12 creat-1.1 na-134 k-4.1 cl-102 hco3-23 angap-13 12:26pm blood glucose-158* urean-13 creat-1.1 na-134 k-4.3 cl-98 hco3-29 angap-11 05:15am blood glucose-164* urean-13 creat-1.0 na-135 k-4.5 cl-98 hco3-31* angap-11 05:45am blood glucose-312* urean-14 creat-1.2 na-133 k-4.1 cl-95* hco3-30* angap-12 07:35am blood glucose-157* urean-13 creat-1.1 na-132* k-4.2 cl-98 hco3-25 angap-13 06:40am blood glucose-198* urean-21* creat-1.2 na-131* k-4.6 cl-97 hco3-27 angap-12 06:00am blood glucose-122* urean-32* creat-1.4* na-134 k-5.0 cl-100 hco3-28 angap-11 07:05pm blood glucose-163* urean-33* creat-1.3* na-132* k-5.0 cl-99 hco3-26 angap-12 05:45am blood calcium-8.6 phos-4.1 mg-1.5* 05:35am blood calcium-8.3* phos-4.0 mg-1.8 05:37am blood calcium-8.4 phos-3.3 mg-1.7 04:57am blood calcium-8.2* phos-4.2 mg-2.0 08:52pm blood calcium-8.5 phos-3.4 mg-1.8 05:00am blood calcium-8.5 phos-3.8 mg-1.8 12:26pm blood calcium-9.2 phos-3.3 mg-1.9 05:15am blood calcium-8.4 phos-3.5 mg-2.0 cholest-145 05:45am blood calcium-8.7 phos-3.5 07:35am blood calcium-8.3* phos-3.4 mg-1.8 06:40am blood calcium-8.5 phos-3.2 mg-1.9 06:00am blood calcium-8.4 phos-3.4 mg-2.0 07:05pm blood calcium-8.9 phos-3.1 mg-2.1 12:16pm blood %hba1c-10.2* 05:15am blood triglyc-229* hdl-29 chol/hd-5.0 ldlcalc-70 06:17pm blood type-art po2-144* pco2-35 ph-7.42 calhco3-23 base xs-0 06:17pm blood glucose-161* lactate-1.2 na-137 k-3.9 cl-110 06:17pm blood hgb-10.5* calchct-32 06:17pm blood freeca-1.04* due to mixed bacterial types ( >= 3 colony types) an abbreviated workup is performed appropriate to the isolates recovered from the site (including a screen for pseudomonas aeruginosa, staphylococcus aureus and beta streptococcus). staph aureus coag +. moderate growth of two colonial morphologies. oxacillin resistant staphylococci must be reported as also resistant to other penicillins, cephalosporins, carbacephems, carbapenems, and beta-lactamase inhibitor combinations. rifampin should not be used alone for therapy. corynebacterium species (diphtheroids). moderate growth. beta streptococci, not group a. moderate growth. sensitivities: mic expressed in mcg/ml _________________________________________________________ staph aureus coag + | clindamycin----------- =>8 r erythromycin---------- =>8 r gentamicin------------ <=0.5 s levofloxacin---------- 4 i oxacillin------------- =>4 r penicillin------------ =>0.5 r rifampin-------------- <=0.5 s tetracycline---------- <=1 s vancomycin------------ <=1 s anaerobic culture (final ): no anaerobes isolated. wound culture (final ): beta streptococcus group b. rare growth. staphylococcus, coagulase negative. rare growth. anaerobic culture (final ): no anaerobes isolated. medical condition: 48 year old man with left 4th toe ulcer reason for this examination: r/o acute cardiopulm process clinical indication: left fourth toe ulcer, rule out an acute cardiopulmonary process prior to surgery. two views of chest: comparison is made to an exam of . the heart size and mediastinal/hilar contours are stable. the pulmonary vasculature is unremarkable. the lungs are clear, without evidence of focal consolidations or pleural effusions. the visualized soft tissues and osseous structures are unremarkable. impression: no acute cardiopulmonary process. no significant change from the exam of . foot, three views: comparison is made to an exam of . overall, there have been no significant changes. again noted are resections of all five metatarsals. there are no new areas of bone destruction or periosteal reactions suggestive of acute osteomyelitis. there are known new fractures or dislocations. the visualized soft tissues are grossly stable. left foot, three views: no previous exams available for comparison. there has been resection of the fifth mid metatarsal. there are no focal areas of osseous destruction or cortical disruption suggestive of acute osteomyelitis. there are no fractures or dislocations. the visualized soft tissues show vascular calcifications. impression: no significant change in the radiographic appearance of the right foot since the exam of . neither foot shows conclusive radiographic evidence of osteomyelitis. if there is a strong clinical suspicion, a dedicated mr exam of the foot may be helpful in further evaluation. medical condition: 48 year old man with infected left ist toe reason for this examination: left lower extremity vein mapping?? conduit 1) venous duplex lower extremity: reason: patient in need of bypass. evaluate for conduit. 2) arterial duplex right lower extremity: reason: patient is status post bypass graft. findings: vein maping: on the left, the greater saphenous vein is patent with diameters of 0.37, 0.26, 0.35, 0.44, 0.38, and 0.59 cm at the ankle, calf, knee, low thigh, high thigh and saphenofemoral junctions respectively. the left lesser saphenous vein is patent with diameters ranging from 0.29 to 0.55 cm. impression: patent left greater and lesser saphenous veins with diameters as noted. arterial duplex: duplex evaluation from the right superficial femoral artery and the posterior tibial artery bypass graft. peak systolic velocities in cm/second are as follows: 99, 41, 70, 105 in the native proximal vessel, proximal anastomosis, distal anastomosis, and native distal vessel respectively. within the graft from proximal to distal velocities are: 54, 45, 41, 49, 58, 47, 52. impression: widely patent right sfa to posterior tibial artery bypass graft without any evidence of stenosis. medical condition: 48 year old man with decreased pulse in le reason for this examination: assess pvr of left le studies: arterial doppler lower extremity. reason: foot ulcer. findings: doppler evaluation using pulse volume recording evaluation was performed of the left lower extremity. there is a significant drop off at the ankle level and at approximately 6 mm at the metatarsals. impression: significant infrapopliteal artery occlusive disease on the left. medical condition: 48 year old man with left 4th toe ulcer- s/p debridement reason for this examination: postop eval indication: a 48-year-old man with left fourth toe ulcer status post debridement. postoperative evaluation. comparison is made with a prior three views of bilateral feet dated . findings: three views left foot: the patient is status post amputation of the left fourth digit at the distal metatarsal joint. surrounding soft tissue packing limits evaluation for the presence of absence of subcutaneous emphysema. diffuse bony demineralization limits assessment of cortical destruction. additionally, a small lucency is seen overlying the prior surgical site at the tip of the amputated fifth metatarsal stump. this is possibly secondary to air and overlying dressing. recommend repeat evaluation without dressing. vascular clips are seen overlying the dorsum of the left foot. additionally, there are diffuse vascular calcifications. impression: postoperative film identifying amputation of fourth digit at the metatarsal/first phalangeal joint. evaluation of surrounding soft tissues, and fifth metatarsal stump from prior amputation is limited secondary to overlying dressing. recommend reevaluation without dressing. reason: 48 y/o male with diabetes and severe pvd. suspected cad. history: forty-eight year old male with diabetes and severe peripheral vascular disease. the patient has suspected coronary artery disease. comparison: no comparisons are available. summary of the preliminary report from the exercise lab: dipyridamole was infused intravenously for 4 minutes at a dose of 0.142 mg/kg/min. there are no anginal symptoms or ischemic ecg changes during this period. two minutes after the cessation of infusion, tc-m sestamibi was administered iv. interpretation: image protocol: gated spect. resting perfusion images were obtained with thallium-201. tracer was injected 15 minutes prior to obtaining the resting images. this study was interpreted using the 17-segment myocardial perfusion model. the image quality is limited due to presence of light amount of soft tissue attenuation. left ventricular cavity is normal. there is a mild decrease in tracer activity in the basilar portion of the inferior wall which was noted to be more prominent in the stress images. however, it improves in the attenuation correction and is likely due to soft tissue attenuation. no other defects were noted. gated images reveal normal wall motion. the calculated left ventricular ejection fraction is 54%. impression: 1) no definite focal ischemia identified. 2) normal left ventricular cavity size and function. the ef = 54%. brief hospital course: : admitted to podiatric surgery bedrest with bathroom privileges : gauze- wet to dry dressing: . linezolid and levoflox ordered. wound culture ordered. pvrs ordered to assess vascular status : clindamycin iv added : pre angio fluids given patient made npo for angiogram : underwent angiogram by vascular service. started on iv heparin. coumadin held. : transferred to vascular service clindamycin and levo discontinued. : p mibi ordered. service consulted for elevated blood sugars. 2.24: pmibi done : underwent left fem-dp bypass graft see op note for details. : underwent hallux debridement by podiatry service. heparin drip stopped procedure. see op note for detaiuls. transfused 2 units for blood loss anemia coumadin restarted pphysical therapy consulted discharged to home medications on admission: atorvastatin calcium 10 mg tablet sig: one (1) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*0* 3. linezolid 600 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 2 weeks: please check complete blood count after first week and after second week. disp:*28 tablet(s)* refills:*0* 4. atenolol 50 mg tablet sig: 1.5 tablets po twice a day. disp:*90 tablet(s)* refills:*0* 5. hydrocodone-acetaminophen 5-500 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed. disp:*30 tablet(s)* refills:*0* 6. valsartan 160 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 7. amlodipine besylate 5 mg tablet sig: one (1) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*0* 8. warfarin sodium 2 mg tablet sig: three (3) tablet po qodhs (every other day (at bedtime)): please check inr in days. disp:*30 tablet(s)* refills:*0* discharge medications: 1. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). disp:*30 tablet, delayed release (e.c.)(s)* refills:*2* 2. atorvastatin calcium 10 mg tablet sig: one (1) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*0* 3. linezolid 600 mg tablet sig: one (1) tablet po q12h (every 12 hours) for 2 weeks: please check complete blood count after first week and after second week. disp:*28 tablet(s)* refills:*0* 4. atenolol 50 mg tablet sig: 1.5 tablets po twice a day. disp:*90 tablet(s)* refills:*0* 5. hydrocodone-acetaminophen 5-500 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed. disp:*30 tablet(s)* refills:*0* 6. valsartan 160 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*0* 7. amlodipine besylate 5 mg tablet sig: one (1) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*0* 8. warfarin sodium 2 mg tablet sig: three (3) tablet po qodhs (every other day (at bedtime)): please check inr in days. disp:*30 tablet(s)* refills:*0* 9. warfarin sodium 5 mg tablet sig: one (1) tablet po qod (). disp:*15 tablet(s)* refills:*0* discharge disposition: home discharge diagnosis: nonhealing left 5th toe ulcer dm htn peripheral vasular disease discharge condition: good discharge instructions: please call doctor for increasing pain not controlled by pain medications, wound redness/increasing drainage/swelling, lightheadedness or any other concerns. please take all medications as prescribed including those for high blood pressure. please return to home regimen for diabetes and take both nph and regular insulin as previously directed. please have your primary care doctor adjust your insulin as needed. for coumadin please follow-up with your primary care doctor to have your inr checked at least weekly at first. please also have a complete blood count checked weekly to monitor potential decrease in your white blood cell count casued by zyvox. please use crutches and try and bear partial weight on your heel only. please follow up with dr. in weeks for staple removal and follow up. please also follow-up with podiatry and with your primary care provider followup instructions: please follow up with dr. in two weeks, please call ( for appointment and directions. please follow up with dr. of podiatry in two week, please call ( for appointment and directions. please follow-up wiht dr. in one week. call ( for appointment and directions. dpm 48-137 procedure: arteriography of femoral and other lower extremity arteries amputation of toe other (peripheral) vascular shunt or bypass local excision of lesion or tissue of bone, other bones aortography transfusion of packed cells diagnoses: ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes with peripheral circulatory disorders, type i [juvenile type], not stated as uncontrolled acute osteomyelitis, ankle and foot unspecified osteomyelitis, ankle and foot 

Answer: The patient is high likely exposed to